Literature DB >> 23166544

A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis.

Ki Hoon Park1, Soon Seog Kwon, Myung Hee Chung, Jeana Kim, Hee Jung Lee, Ji-Won Min, Yong Hyun Kim.   

Abstract

Pulmonary mucosa-associated lymphoid tissue-derived (MALT) lymphoma is a rare disease. This disorder is considered to be a model of antigen-driven lymphoma, which is driven either by autoantigens or by chronic inflammatory conditions. Low-grade B-cell MALT lymphoma may develop from a nonneoplastic pulmonary lymphoproliferative disorder, such as lymphocytic interstitial pneumonitis (LIP). A recent estimate predicts that less than 5% of LIP patients acquire malignant, low-grade, B-cell lymphoma. In Korea, there has been no previous report of malignant low-grade, B-cell lymphoma, acquired from LIP. Here, we present the case of a patient with LIP that developed into pulmonary MALT lymphoma, six years after diagnosis.

Entities:  

Keywords:  Lung Diseases, Interstitial; Lymphoid Tissue; Lymphoma; Lymphoproliferative Disorders

Year:  2012        PMID: 23166544      PMCID: PMC3492375          DOI: 10.4046/trd.2012.73.2.115

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  14 in total

1.  Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.

Authors:  B Royer; D Cazals-Hatem; J Sibilia; F Agbalika; J M Cayuela; T Soussi; F Maloisel; J P Clauvel; J C Brouet; X Mariette
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

Review 2.  Structure and function of bronchus-associated lymphoid tissue (BALT).

Authors:  T Sminia; G J van der Brugge-Gamelkoorn; S H Jeurissen
Journal:  Crit Rev Immunol       Date:  1989       Impact factor: 2.214

Review 3.  Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation.

Authors:  Felipe Suarez; Olivier Lortholary; Olivier Hermine; Marc Lecuit
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

4.  Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.

Authors:  R Borie; M Wislez; G Thabut; M Antoine; A Rabbat; L-J Couderc; I Monnet; H Nunes; F-X Blanc; H Mal; A Bergeron; D Dusser; D Israël-Biet; B Crestani; J Cadranel
Journal:  Eur Respir J       Date:  2009-06-18       Impact factor: 16.671

Review 5.  Pulmonary parenchymal involvement of low-grade lymphoproliferative disorders.

Authors:  Kyung-Hyun Do; Jin Seong Lee; Joon Beom Seo; Jae Woo Song; Myung Jin Chung; Jeong-Nam Heo; Koun-Sik Song; Tae-Hwan Lim
Journal:  J Comput Assist Tomogr       Date:  2005 Nov-Dec       Impact factor: 1.826

6.  Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue.

Authors:  P Isaacson; D H Wright
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

7.  Reactive pulmonary lymphoid disorders.

Authors:  A G Nicholson; A C Wotherspoon; T C Diss; D M Hansell; R Du Bois; M N Sheppard; P G Isaacson; B Corrin
Journal:  Histopathology       Date:  1995-05       Impact factor: 5.087

8.  Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients.

Authors:  Young A Bae; Kyung Soo Lee; Joungho Han; Young-Hyeh Ko; Byung-Tae Kim; Myung Jin Chung; Tae Sung Kim
Journal:  Chest       Date:  2007-12-10       Impact factor: 9.410

Review 9.  Primary pulmonary lymphoma.

Authors:  J Cadranel; M Wislez; M Antoine
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.